Food and Drug Administration
Research on Complex Generics
Research on Complex Generics is a funding opportunity from Food and Drug Administration, up to $2.5M, closing December 14, 2026.
Overview
The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.